Impact of Biologic Agents on the Immune Response Induced by the Additional Dose of SARS-CoV-2 Vaccine in Inflammatory Bowel Disease Patients.
Laura RamosMiriam Hernández-PortoMarta Carrillo-PalauInmaculada Alonso-AbreuCristina ReygosaManuel Hernandez-GuerraPublished in: Inflammatory bowel diseases (2022)